Privium Fund Management B.V. Albireo Pharma, Inc. Transaction History

Privium Fund Management B.V.

  • $401 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$18.54 - $37.29 $955,792 - $1.92 Million
-51,553 Reduced 14.65%
300,252 $5.96 Million
Q1 2022

May 10, 2022
SELL
$23.94 - $33.74 $653,849 - $921,506
-27,312 Reduced 7.2%
351,805 $10.5 Million
Q4 2021

Feb 09, 2022
BUY
$21.19 - $31.29 $8.03 Million - $11.9 Million
379,117 New
379,117 $8.96 Million

Others Institutions Holding ALBO

# of Institutions
4
Shares Held
865
Call Options Held
0
Put Options Held
0
View Full List

About ALBIREO PHARMA, INC.

ALBO Quotes by TradingView
  • Ticker ALBO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,612,500
  • Description
  • Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...
More about ALBO
Track This Portfolio

Track Privium Fund Management B.V. Portfolio

Follow Privium Fund Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email